Agota has over 25 years of experience with design and implementation of HEOR and market access studies from conceptualization to publication. She is transitioning to Genesis from Fortrea where she served as the Health Economics & HTA Lead; spent the past 20 years leading multi-disciplinary teams to deliver pharmacoeconomic models across all phases of product development. She supported various stakeholders with her HEOR research experience alongside clinical trials and real-world evidence studies, including core health economic model development and country-specific HTA submissions, as well as post launch health economic tools and publications, including in leading HEOR and therapeutic area journals. She held leadership roles in health economic business strategy development and implementation, staff development, client and key account relations, and collaboration with stakeholders. Agota holds a PhD and an MSc in Health Economics from the University of York, United Kingdom. Based in York, UK, Agota leads the HEOR Value & Evidence team. Executive Director, Head of HEOR Value and Evidence.
